Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo.
Publication
, Journal Article
Mannelli, P
Published in: Evid Based Ment Health
November 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Evid Based Ment Health
DOI
EISSN
1468-960X
Publication Date
November 2011
Volume
14
Issue
4
Start / End Page
106
Location
England
Related Subject Headings
- Psychiatry
- 5203 Clinical and health psychology
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Mannelli, P. (2011). Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo. Evid Based Ment Health, 14(4), 106. https://doi.org/10.1136/ebmh.2011.100153
Mannelli, Paolo. “Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo.” Evid Based Ment Health 14, no. 4 (November 2011): 106. https://doi.org/10.1136/ebmh.2011.100153.
Mannelli P. Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo. Evid Based Ment Health. 2011 Nov;14(4):106.
Mannelli, Paolo. “Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo.” Evid Based Ment Health, vol. 14, no. 4, Nov. 2011, p. 106. Pubmed, doi:10.1136/ebmh.2011.100153.
Mannelli P. Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo. Evid Based Ment Health. 2011 Nov;14(4):106.
Published In
Evid Based Ment Health
DOI
EISSN
1468-960X
Publication Date
November 2011
Volume
14
Issue
4
Start / End Page
106
Location
England
Related Subject Headings
- Psychiatry
- 5203 Clinical and health psychology
- 4202 Epidemiology
- 3202 Clinical sciences
- 1117 Public Health and Health Services